Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CEBPA |
| Upstream (Parents) |
|---|
| (<<) CYR61 → CEBPA |
| (<<) E2F6 → CEBPA |
| (<<) G0S2 → CEBPA |
| (<<) GNA15 → CEBPA |
| (<<) GPNMB → CEBPA |
| (<<) GPX3 → CEBPA |
| (<<) GRN → CEBPA |
| (<<) GYPC → CEBPA |
| (<<) HADH → CEBPA |
| (<<) ISLR → CEBPA |
| (<<) MYL9 → CEBPA |
| (<<) NFAT5 → CEBPA |
| (<<) NFATC3 → CEBPA |
| (<<) PTGER4 → CEBPA |
| (<<) RAB15 → CEBPA |
| (<<) RAB5C → CEBPA |
| (<<) RRAS → CEBPA |
| (<<) SULF1 → CEBPA |
| (<<) TIMP3 → CEBPA |
| (<<) VEGFB → CEBPA |
| (<<) VIM → CEBPA |
| (<<) YWHAB → CEBPA |
| Downstream (Children) |
|---|
| CEBPA → ALPPL2 (>>) |
| CEBPA → CDCP1 (>>) |
| CEBPA → CHI3L1 (>>) |
| CEBPA → DOCK9 (>>) |
| CEBPA → FAM136A (>>) |
| CEBPA → GLI3 (>>) |
| CEBPA → KRT16 (>>) |
| CEBPA → PLCH2 (>>) |
